Andrea S. James, Chief Financial Officer at Oncocyte Corp (OCX), bought 195,122 shares at $2.05 ($400K) on 2025-02-07, disclosed to the SEC on 2025-02-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 97,561 | $200K | 50.0% |
| 2 | $2.05 | 97,561 | $200K | 50.0% |
| Total | $2.05 avg | 195,122 | $400K | 100% |
| Filing → |